Yes, we have BSL-2 space at our facilities in Ann Arbor, MI, and Denver, PA, and can work with a wide range of infectious agents. Learn more about our infectious disease and vaccine capabilities.

Yes, our discovery and safety teams work closely to efficiently run a study with efficacy, safety and PK, all under one roof. Explore our drug metabolism and pharmacokinetics (DMPK) solutions.

Yes, we have an inhalation delivery team at our Huntingdon site that can administer drug by the inhalation route for evaluation of efficacy, PK and safety.

Discovery DMPK screening can be done in a cost-effective manner. By leveraging technologies and resources, you can quickly and efficiently identify potential drug candidates with the desired pharmacokinetic properties. Learn about our in vitro screening capabilities.

Yes. Because our discovery teams are closely associated with safety teams, we can readily run combined studies that capture all these endpoints, allowing you to be more efficient investigating your discovery compounds.

Yes, we offer a wide range of non-GLP animal telemetry models to test your tool compound on blood pressure, ECG and cardiac function to help understand the cardiovascular risk. Explore cardiovascular safety assessments.